DK176387D0 - Fremgangsmaade til frembringelse af et funktionelt polypeptid i en eukaryot vaertscelle ved anvendelse af en rekombinant dna udtrykkelsesvektor omfattende en bk virusforstaerker - Google Patents

Fremgangsmaade til frembringelse af et funktionelt polypeptid i en eukaryot vaertscelle ved anvendelse af en rekombinant dna udtrykkelsesvektor omfattende en bk virusforstaerker

Info

Publication number
DK176387D0
DK176387D0 DK176387A DK176387A DK176387D0 DK 176387 D0 DK176387 D0 DK 176387D0 DK 176387 A DK176387 A DK 176387A DK 176387 A DK176387 A DK 176387A DK 176387 D0 DK176387 D0 DK 176387D0
Authority
DK
Denmark
Prior art keywords
polypeptime
eukaryot
virus
amplifier
creating
Prior art date
Application number
DK176387A
Other languages
English (en)
Other versions
DK176387A (da
Inventor
Brian William Grinnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK176387D0 publication Critical patent/DK176387D0/da
Publication of DK176387A publication Critical patent/DK176387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK176387A 1986-04-09 1987-04-07 Fremgangsmaade til frembringelse af et funktionelt polypeptid i en eukaryot vaertscelle ved anvendelse af en rekombinant dna udtrykkelsesvektor omfattende en bk virusforstaerker DK176387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84999986A 1986-04-09 1986-04-09

Publications (2)

Publication Number Publication Date
DK176387D0 true DK176387D0 (da) 1987-04-07
DK176387A DK176387A (da) 1987-11-13

Family

ID=25307027

Family Applications (1)

Application Number Title Priority Date Filing Date
DK176387A DK176387A (da) 1986-04-09 1987-04-07 Fremgangsmaade til frembringelse af et funktionelt polypeptid i en eukaryot vaertscelle ved anvendelse af en rekombinant dna udtrykkelsesvektor omfattende en bk virusforstaerker

Country Status (10)

Country Link
EP (3) EP0576049A1 (da)
JP (5) JP3162056B2 (da)
AU (1) AU605479B2 (da)
CA (2) CA1318619C (da)
DE (3) DE3752382T2 (da)
DK (1) DK176387A (da)
ES (3) ES2237755T3 (da)
HU (1) HU211391B (da)
IE (3) IE980258A1 (da)
IL (5) IL98886A (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613481D0 (en) * 1986-06-04 1986-07-09 Diatech Ltd Translation of mrna
CN105339495A (zh) * 2013-07-11 2016-02-17 宝生物工程株式会社 制备无包膜病毒的方法
US10494421B2 (en) 2014-02-10 2019-12-03 Univercells Nv System, apparatus and method for biomolecules production
US10023846B2 (en) 2014-07-10 2018-07-17 Takara Bio Inc. Production method for non-enveloped virus particles
CN107109374B (zh) 2015-01-09 2021-04-06 宝生物工程株式会社 用于生产无包膜病毒颗粒的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327860D0 (en) * 1983-10-18 1983-11-16 Fujisawa Pharmaceutical Co Monoclonal antiprotein c antibody
JPH0789930B2 (ja) * 1984-03-08 1995-10-04 大正製薬株式会社 ウイルス性転写促進配列
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
EP0349598A1 (en) * 1987-03-13 1990-01-10 Schering Corporation Method for stimulating gene expression
JPH0660120A (ja) * 1992-08-06 1994-03-04 Sharp Corp 可変長データの格納方法及び検索装置

Also Published As

Publication number Publication date
IL98886A (en) 1992-12-01
JP2958286B2 (ja) 1999-10-06
EP0699764B1 (en) 2005-03-09
JP3162056B2 (ja) 2001-04-25
ES2227514T3 (es) 2005-04-01
HU211391B (en) 1995-11-28
IE980258A1 (en) 1987-10-09
HK1009605A1 (en) 1999-06-04
IE870912L (en) 1987-10-09
AU7117587A (en) 1987-10-15
CA1318619C (en) 1993-06-01
JPH099980A (ja) 1997-01-14
DE3752382T2 (de) 2005-12-29
HUT43633A (en) 1987-11-30
IL82093A0 (en) 1987-10-30
IE980257A1 (en) 1987-10-09
IL98887A0 (en) 1992-07-15
IE81065B1 (en) 2000-01-12
IL98886A0 (en) 1992-07-15
EP0584845A1 (en) 1994-03-02
JP2877228B2 (ja) 1999-03-31
DE3752134D1 (de) 1997-12-04
EP0576049A1 (en) 1993-12-29
JPH11346789A (ja) 1999-12-21
DE3752376D1 (de) 2004-10-14
DE3752382D1 (de) 2005-04-14
JP2001145496A (ja) 2001-05-29
HK1021861A1 (en) 2000-07-07
JPH1057081A (ja) 1998-03-03
DE3752134T2 (de) 1998-03-19
JPS6312296A (ja) 1988-01-19
CA1340384C (fr) 1999-02-09
IL82093A (en) 1992-12-01
DK176387A (da) 1987-11-13
ES2237755T3 (es) 2005-08-01
IL98887A (en) 1992-12-01
ES2107997T3 (es) 1997-12-16
AU605479B2 (en) 1991-01-17
EP0699764A1 (en) 1996-03-06
EP0584845B1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
DK374087A (da) Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne
AU8223187A (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
DE3786592D1 (de) Transformation von trichoderma.
DK11684A (da) Fremgangsmaade til udtrykkelse af et funktionelt polypeptid i streptomyces ved hjaelp af en rekombinant dna udtrykkelsesvektor
DK509089A (da) Fremgangsmaade til dyrkning af mammale epidermale celler
DK166657C (da) Uorganisk filtreringsmembran, fremgangsmaade til fremstilling af membranen samt membranens anvendelse til separering af proteiner i en oploesning
DK537087A (da) Fremgangsmaade til modificering af lipid-strukturen i cellemembraner samt praeparat til anvendelse herved
DK176387A (da) Fremgangsmaade til frembringelse af et funktionelt polypeptid i en eukaryot vaertscelle ved anvendelse af en rekombinant dna udtrykkelsesvektor omfattende en bk virusforstaerker
DK87887A (da) Ekspression af humant il-2 i pattedyrceller ved hjaelp af et rekombinant poxvirus
DK187083D0 (da) Farvningssystem til brug ved farvning af biologiske praeparater
DK664487D0 (da) Fremgangsmaade til bestemmelse af indholdet af oploeste stoffer i et oploesningsmiddel
DK426585D0 (da) Fremgangsmaade til udtrykkelse af et funktionelt polypeptid i bacillusog vektor til brug ved fremgangsmaaden
DK520479A (da) Fremgangsmaade til fremstilling af et pigmentpraeparat ved indarbejdning af pigmentet i en smelte af et polymert eller monomert organisk materiale samt disse pigmentpraeparater selv
DK429485A (da) Fremgangsmaade til udtrykkelse af et funktionelt polypeptid i streptomyces og vektor til brug ved fremgangsmaaden
DK72187A (da) Fremgangsmaade til modificering af lipidstrukturen, funktionen og udtrykkelsen af cellemembraber og farmaceutiske praeparater til anvendelse ved fremgangsmaaden
DK99985D0 (da) Rekombinant dna-udtrykkelsesvektor til brug ved fremstilling af funktionelle polypeptider
DK99289A (da) Fremgangsmaade til expression af ikke-seleterbare gener i eukariotiske celler
DK125289D0 (da) Dna-struktur, omfattende en aktivator-stimuleret promotor til udtrykkelse af et oensket protein, samt fremgangsmaade til udtrykkelse af proteinet ved hjaelp af dna-strukturen
DK195187D0 (da) Fremgangsmaade til indfoering af funktionelle grupper i iod-polyfluoralkaner samt forbindelser opnaaet ved fremgangsmaaden
DK116487A (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
DK351588A (da) Fremgangsmaade til modificering af cellemembran
DK326285D0 (da) Dna-sekvens, expressionsvektor og anvendelse heraf til expression afstrukturgener i bakterier ved dyrkning i teknisk maalestok
DK432285D0 (da) Fremgangsmaade til kloning af endogent modificeret streptomycetes-dna i restriktionsloese hetero-specifikke vaertsceller
DK384789D0 (da) Fremgangsmaade til aktivering af maalceller
DK104991D0 (da) Ekspression af hiv-proteiner i drosophila-celler

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PBP Patent lapsed

Effective date: 20140131